|
Prospector Profile 07.1410
|
|
Advanced Medical Optics, Inc. |
NAICS |
339112 |
1700 E. St. Andrew Place
Santa Ana, CA 92705 |
Description |
Medical Instruments Mfg. |
(714) 247-8200 |
Employees |
3800 |
http://www.amo-inc.com |
Revenue |
(mil) |
997.5000 |
|
Income |
(mil) |
79.4700 |
|
Assets |
(mil) |
2013.9000 |
|
Liability |
(mil) |
1297.9100 |
|
(for the year ended 2006-12-31) |
|
Category:
Low Rating
|
|
Event:
Moody's Investors Service downgraded Advanced Medical Optics Inc.'s Convertible Subordinated Notes (to LGD5/80% from LGD5/81%) due 2024 to Caa1 from B3.
|
|
Intellectual Property:
The Company has rights to over 1,270 granted and issued patents and over 1,000 pending patent applications relating to aspects of the technology incorporated in many of its products. The Company owns or has rights to material trademarks or trade names used in conjunction with the sale of its products, which include Advanced Medical Optics® , Amadeus™, AMO®, Baerveldt®, blink™, Blink-n-Clean®, ClariFlex®, Complete® , Complete MoisturePLUS™, Complete Revitalize® ,Consept®, Consept 1 Step™, Custom Vue® , Healon®, Healon5®, Healon GV®, OptiEdge™, Oxysept®, Oxysept 1 Step™, ReZoom®, Sensar®, Sovereign®, Sovereign Compact™, Stabileyes®, Star S4 IR™, Tecnis®, The Unfolder®, UltraCare®, Ultrazyme®, Verisyse™, VISX®, WaveScan®, and WhiteStar®. Amadeus is a trademark of SIS Ltd. [SEC Filing 10-K 03-01-07]
|
|
Description:
The Company develops, manufactures and markets surgical devices for the eyes worldwide.
|
|
Officers:
James V. Mazzo (CEO); Richard A. Meier (COO); Christopher G. Chavez (Dir); Holger Heidrich Ph.D (VP); C. Russell Trenary III, (VP)
|
|
Auditor:
PricewaterhouseCoopers LLP
|
|
Securities:
Common Stock Symbol EYE; NYSE;
60,458,073 common shares outstanding as of July 31, 2007.
|
|
|
|
return to main page |
|
|